Back to Search
ROBERT FLANIGAN, MD
MD
Urology Physician
NPI: 1508830456IndividualAccepts Medicare
Education
CLVLND CLINIC LERNER COLLEGE OF MED OF CASE WSTN RSV UNIVERSITY
Class of 1972
Research & Publications (20)
Words of wisdom. Re: Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma.
PMID 19650236·Eur Urol·2009
8-other
An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial.
PMID 18602688·Lancet·2008
3-trial
Does lymphadenectomy improve cancer-specific survival in patients with renal cell carcinoma?
PMID 16474543·Nat Clin Pract Urol·2005
8-other
Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis.
PMID 14767273·J Urol·2004
3-trial
Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.
PMID 11759643·N Engl J Med·2001
3-trial
The role of radical nephrectomy in metastatic renal cell carcinoma.
PMID 11354539·Semin Urol Oncol·2001
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2160 S FIRST AVE, FAHEY BLDG ROOM 270
MAYWOOD, IL 60153 - Phone
- (708) 216-5100
Quick Facts
- NPI
- 1508830456
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 54
- Publications
- 20
Are you this provider?
Claim Your Profile